The use of PET in Parkinson's disease.
Shinotoh, H
The use of PET in Parkinson's disease. [electronic resource] - Brain and cognition Aug 1995 - 297-310 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review
0278-2626
10.1006/brcg.1995.1259 doi
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine--therapeutic use
Aging
Antiparkinson Agents--therapeutic use
Binding Sites
Brain--diagnostic imaging
Corpus Striatum--physiopathology
Diagnosis, Differential
Humans
Neurotransmitter Agents--physiology
Parkinson Disease--diagnosis
Receptors, Dopamine D2--physiology
Substantia Nigra--physiopathology
Tomography, Emission-Computed
The use of PET in Parkinson's disease. [electronic resource] - Brain and cognition Aug 1995 - 297-310 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review
0278-2626
10.1006/brcg.1995.1259 doi
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine--therapeutic use
Aging
Antiparkinson Agents--therapeutic use
Binding Sites
Brain--diagnostic imaging
Corpus Striatum--physiopathology
Diagnosis, Differential
Humans
Neurotransmitter Agents--physiology
Parkinson Disease--diagnosis
Receptors, Dopamine D2--physiology
Substantia Nigra--physiopathology
Tomography, Emission-Computed